A Study to Evaluate the Safety and Pharmacokinetics of BX-001N in Healthy Participants

Clinical trial NCT06097702 · COMPLETED

Trial details

NCT number: NCT06097702
Sponsor: Bilix Co.,Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Ischemia-reperfusion Injury

Start date: 2023-11-17
Primary completion: 2024-11-06
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.